Director Shareholding
November 25 2002 - 11:40AM
UK Regulatory
RNS Number:2499E
Cambridge Antibody Tech Group PLC
25 November 2002
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
1) Name of company
Cambridge Antibody Technology
2) Name of director
Kevin Johnson
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a
non-beneficial interest or in the case of an individual holder if it is a
holding of that person's spouse or children under the age of 18 or in respect of
a non-beneficial interest
As in 2 above
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them (if notified)
Computershare Trustees Limited
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
As in 2 above
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
Award of free shares under Inland Revenue Approved Share Incentive Plan
7) Number of shares/amount of
stock acquired
253
8) Percentage of issued class
0.0007%
9) Number of shares/amount
of stock disposed
0
10) Percentage of issued class
0%
11) Class of security
Ordinary 10 pence shares
12) Price per share
#5.13
13) Date of transaction
22 November 2002
14) Date company informed
22 November 2002
15) Total holding following this notification
64,087
16) Total percentage holding of issued class following this notification
0.18%
If a director has been granted options by the company please complete the
following boxes
17) Date of grant
22 November 2002
18) Period during which or date on which exercisable
Exercisable from 22 November 2005 to 21 November 2012 subject to satisfaction of
performance condition
19) Total amount paid (if any) for grant of the option
Nil
20) Description of shares or debentures involved: class, number
Grant of 7,451 options over ordinary 10 pence shares under Company Share Option
Plan
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
#5.13
22) Total number of shares or debentures over which options held
following this notification
119,054
23) Any additional information
None
24) Name of contact and telephone number for queries
Justin Hoskins, 01763 263233
25) Name and signature of authorised company official responsible for
making this notification
Diane Mellett, Company Secretary
Date of Notification 25 November 2002
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
1) Name of company
Cambridge Antibody Technology
2) Name of director
John Aston
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a
non-beneficial interest or in the case of an individual holder if it is a
holding of that person's spouse or children under the age of 18 or in respect of
a non-beneficial interest
As in 2 above
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them (if notified)
Computershare Trustees Limited
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
As in 2 above
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
Award of free shares under Inland Revenue Approved Share Incentive Plan
7) Number of shares/amount of
stock acquired
331
8) Percentage of issued class
0.0009%
9) Number of shares/amount
of stock disposed
0
10) Percentage of issued class
0%
11) Class of security
Ordinary 10 Pence
12) Price per share
#5.13
13) Date of transaction
22 November 2002
14) Date company informed
22 November 2002
15) Total holding following this notification
28,188
16) Total percentage holding of issued class following this notification
0.08%
If a director has been granted options by the company please complete the
following boxes
17) Date of grant
22 November 2002
18) Period during which or date on which exercisable
Exercisable from 22 November 2005 to 21 November 2012 subject to satisfaction of
performance condition
19) Total amount paid (if any) for grant of the option
Nil
20) Description of shares or debentures involved: class, number
Grant of 7,579 options over ordinary 10 pence shares under Company Share Option
Plan
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
#5.13
22) Total number of shares or debentures over which options held
following this notification
196,051
23) Any additional information
None
24) Name of contact and telephone number for queries
Justin Hoskins, 01763 263233
25) Name and signature of authorised company official responsible for
making this notification
Diane Mellett, Company Secretary
Date of Notification 25 November 2002
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
1) Name of company
Cambridge Antibody Technology
2) Name of director
David Glover
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a
non-beneficial interest or in the case of an individual holder if it is a
holding of that person's spouse or children under the age of 18 or in respect of
a non-beneficial interest
As in 2 above
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them (if notified)
Computershare Trustees Limited
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
As in 2 above
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
Award of free shares under Inland Revenue Approved Share Incentive Plan
7) Number of shares/amount of
stock acquired
253
8) Percentage of issued class
0.0007%
9) Number of shares/amount
of stock disposed
0
10) Percentage of issued class
0%
11) Class of security
Ordinary 10 pence shares
12) Price per share
#5.13
13) Date of transaction
22 November 2002
14) Date company informed
22 November 2002
15) Total holding following this notification
10,919
16) Total percentage holding of issued class following this notification
0.03%
If a director has been granted options by the company please complete the
following boxes
17) Date of grant
22 November 2002
18) Period during which or date on which exercisable
Exercisable from 22 November 2005 to 21 November 2012 subject to the
satisfaction of performance condition
19) Total amount paid (if any) for grant of the option
Nil
20) Description of shares or debentures involved: class, number
Grant of 7,451 options over 10 pence ordinary shares under Company Share Option
Plan
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
#5.13
22) Total number of shares or debentures over which options held
following this notification
120,694
23) Any additional information
None
24) Name of contact and telephone number for queries
Justin Hoskins, 01763 263233
25) Name and signature of authorised company official responsible for
making this notification
Diane Mellett, Company Secretary
Date of Notification 25 November, 2002 November 2002
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
1) Name of company
Cambridge Antibody Technology
2) Name of director
Aaron Klug
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a
non-beneficial interest or in the case of an individual holder if it is a
holding of that person's spouse or children under the age of 18 or in respect of
a non-beneficial interest
As in 2 above
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them (if notified)
Greenwood Nominees Limited
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
As in 2 above
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
Regular annual payment of part of directors fee in lieu of cash consideration
7) Number of shares/amount of
stock acquired
1,023
8) Percentage of issued class
0.003%
9) Number of shares/amount
of stock disposed
0
10) Percentage of issued class
0%
11) Class of security
Ordinary 10 pence
12) Price per share
#5.13
13) Date of transaction
22 November 2002
14) Date company informed
22 November 2002
15) Total holding following this notification
28,950
16) Total percentage holding of issued class following this notification
0.08%
If a director has been granted options by the company please complete the
following boxes
17) Date of grant
18) Period during which or date on which exercisable
19) Total amount paid (if any) for grant of the option
20) Description of shares or debentures involved: class, number
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
22) Total number of shares or debentures over which options held
following this notification
23) Any additional information
None
24) Name of contact and telephone number for queries
Justin Hoskins, 01763 263233
25) Name and signature of authorised company official responsible for
making this notification
Diane Mellett, Company Secretary
Date of Notification 25 November 2002
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
1) Name of company
Cambridge Antibody Technology
2) Name of director
Peter Garland
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a
non-beneficial interest or in the case of an individual holder if it is a
holding of that person's spouse or children under the age of 18 or in respect of
a non-beneficial interest
As in 2 above
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them (if notified)
Greenwood Nominees Limited
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
As in 2 above
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
Regular annual payment of directors fee in lieu of cash consideration
7) Number of shares/amount of
stock acquired
2,192
8) Percentage of issued class
0.006%
9) Number of shares/amount
of stock disposed
0
10) Percentage of issued class
0%
11) Class of security
Ordinary 10 pence shares
12) Price per share
#5.13
13) Date of transaction
22 November 2002
14) Date company informed
22 November 2002
15) Total holding following this notification
40,017
16) Total percentage holding of issued class following this notification
0.11%
If a director has been granted options by the company please complete the
following boxes
17) Date of grant
18) Period during which or date on which exercisable
19) Total amount paid (if any) for grant of the option
20) Description of shares or debentures involved: class, number
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
22) Total number of shares or debentures over which options held
following this notification
23) Any additional information
None
24) Name of contact and telephone number for queries
Justin Hoskins, 01763 263233
25) Name and signature of authorised company official responsible for
making this notification
Diane Mellett, Company Secretary
Date of Notification 25 November 2002
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
1) Name of company
Cambridge Antibody Technology
2) Name of director
John Stocker
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a
non-beneficial interest or in the case of an individual holder if it is a
holding of that person's spouse or children under the age of 18 or in respect of
a non-beneficial interest
As in 2 above
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them (if notified)
Greenwood Nominees Limited
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
As in 2 above
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
Regular annual payment of part of directors fees in lieu of cash consideration
7) Number of shares/amount of
stock acquired
1,023
8) Percentage of issued class
0.003%
9) Number of shares/amount
of stock disposed
0
10) Percentage of issued class
0%
11) Class of security
Ordinary 10 pence
12) Price per share
#5.13
13) Date of transaction
22 November 2002
14) Date company informed
22 November 2002
15) Total holding following this notification
79,622
16) Total percentage holding of issued class following this notification
0.22%
If a director has been granted options by the company please complete the
following boxes
17) Date of grant
18) Period during which or date on which exercisable
19) Total amount paid (if any) for grant of the option
20) Description of shares or debentures involved: class, number
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
22) Total number of shares or debentures over which options held
following this notification
23) Any additional information
None
24) Name of contact and telephone number for queries
Justin Hoskins, 01763 263233
25) Name and signature of authorised company official responsible for
making this notification
Diane Mellett, Company Secretary
Date of Notification 25 November 2002
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
1) Name of company
Cambridge Antibody Technology
2) Name of director
James Foght
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a
non-beneficial interest or in the case of an individual holder if it is a
holding of that person's spouse or children under the age of 18 or in respect of
a non-beneficial interest
As in 2 above
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them (if notified)
Greenwood Nominees Limited
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
As in 2 above
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
Regular annual payment of part of directors fee in lieu of cash consideration
7) Number of shares/amount of
stock acquired
1,023
8) Percentage of issued class
0.003%
9) Number of shares/amount
of stock disposed
0
10) Percentage of issued class
0%
11) Class of security
Ordinary 10 pence
12) Price per share
#5.13
13) Date of transaction
22 November 2002
14) Date company informed
22 November 2002
15) Total holding following this notification
4,141
16) Total percentage holding of issued class following this notification
0.011%
If a director has been granted options by the company please complete the
following boxes
17) Date of grant
18) Period during which or date on which exercisable
19) Total amount paid (if any) for grant of the option
20) Description of shares or debentures involved: class, number
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
22) Total number of shares or debentures over which options held
following this notification
23) Any additional information
None
24) Name of contact and telephone number for queries
Justin Hoskins, 01763 263233
25) Name and signature of authorised company official responsible for
making this notification
Diane Mellett, Company Secretary
Date of Notification 25 November 2002
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
1) Name of company
Cambridge Antibody Technology
2) Name of director
Paul Nicholson
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a
non-beneficial interest or in the case of an individual holder if it is a
holding of that person's spouse or children under the age of 18 or in respect of
a non-beneficial interest
As in 2 above
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them (if notified)
As in 2 above
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
As in 2 above
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
Regular annual payment of part of directors fee in lieu of cash consideration
7) Number of shares/amount of
stock acquired
1,023
8) Percentage of issued class
0.003%
9) Number of shares/amount
of stock disposed
0
10) Percentage of issued class
0%
11) Class of security
Ordinary 10 pence
12) Price per share
#5.13
13) Date of transaction
22 November 2002
14) Date company informed
22 November 2002
15) Total holding following this notification
5,764
16) Total percentage holding of issued class following this notification
0.02%
If a director has been granted options by the company please complete the
following boxes
17) Date of grant
18) Period during which or date on which exercisable
19) Total amount paid (if any) for grant of the option
20) Description of shares or debentures involved: class, number
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
22) Total number of shares or debentures over which options held
following this notification
23) Any additional information
None
24) Name of contact and telephone number for queries
Justin Hoskins, 01763 263233
25) Name and signature of authorised company official responsible for
making this notification
Diane Mellett, Company Secretary
Date of Notification 25 November 2002
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
1) Name of company
Cambridge Antibody Technology
2) Name of director
Uwe Bicker
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a
non-beneficial interest or in the case of an individual holder if it is a
holding of that person's spouse or children under the age of 18 or in respect of
a non-beneficial interest
As in 2 above
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them (if notified)
As in 2 above
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
As in 2 above
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
Regular annual payment of part of directors fee in lieu of cash consideration
7) Number of shares/amount of
stock acquired
1,023
8) Percentage of issued class
0.003%
9) Number of shares/amount
of stock disposed
0
10) Percentage of issued class
0%
11) Class of security
Ordinary 10 pence shares
12) Price per share
#5.13
13) Date of transaction
22 November 2002
14) Date company informed
22 November 2002
15) Total holding following this notification
3,481
16) Total percentage holding of issued class following this notification
0.01%
If a director has been granted options by the company please complete the
following boxes
17) Date of grant
18) Period during which or date on which exercisable
19) Total amount paid (if any) for grant of the option
20) Description of shares or debentures involved: class, number
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
22) Total number of shares or debentures over which options held
following this notification
23) Any additional information
None
24) Name of contact and telephone number for queries
Justin Hoskins, 01763 269441
25) Name and signature of authorised company official responsible for
making this notification
Diane Mellett, Company Secretary
Date of Notification 25 November 2002
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSEAKFSADPAFFE
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Jul 2023 to Jul 2024
